A Case Control Study of the Effectiveness of Q/LAIV Versus Inactivated Influenza Vaccine and No Vaccine in Subjects 2-17 Years of Age

Trial Profile

A Case Control Study of the Effectiveness of Q/LAIV Versus Inactivated Influenza Vaccine and No Vaccine in Subjects 2-17 Years of Age

Suspended
Phase of Trial: Phase IV

Latest Information Update: 04 Oct 2017

At a glance

  • Drugs MEDI 3250 (Primary) ; Influenza virus vaccine
  • Indications Influenza virus infections
  • Focus Therapeutic Use
  • Acronyms ICICLE
  • Sponsors MedImmune
  • Most Recent Events

    • 04 Oct 2017 Results related to US data for 2005-16 influenza season published in the Clinical Infectious Diseases
    • 10 Apr 2017 Results (n=1696) published in the Vaccine.
    • 06 Sep 2016 Results of post-hoc analysis investigating the association between the lack of LAIV effectiveness against H1N1pdm09 strains and vaccine lot handling conditions during distribution published in the Vaccine.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top